BioCentury
ARTICLE | Company News

SuperGen, Stehlin Foundation for Cancer Research deal

November 22, 1999 8:00 AM UTC

SUPG acquired exclusive worldwide rights to camptothecin compounds and other anticancer compounds discovered by the foundation. SUPG already holds exclusive worldwide rights from the foundation to rub...